Genomics Inform.  2023 Sep;21(3):e43. 10.5808/gi.23054.

Molecular docking Study of Nuciferine as a Tyrosinase Inhibitor and Its Therapeutic Potential for Hyperpigmentation

• Veerichetty V
• Saravanabavan I

• KMID: 2547077
• DOI: http://doi.org/10.5808/gi.23054

Abstract

Melanin is synthesized by tyrosinase to protect the skin from ultraviolet light. However, overproduction and accumulation of melanin can result in hyperpigmentation and skin melanoma. Tyrosinase inhibitors are commonly used in the treatment of hyperpigmentation. Natural tyrosinase inhibitors are often favored over synthetic ones due to the potential side effects of the latter, which can include skin irritation, allergies, and other adverse reactions. Nuciferine, an alkaloid derived from Nelumbo nucifera, exhibits potent antioxidant and anti-proliferative properties. This study focused on the in silico screening of nuciferine for anti-tyrosinase activity, using kojic acid, ascorbic acid, and resorcinol as standards. The tyrosinase protein target was selected through homology modeling. The residues of the substrate binding pocket and active site pockets were identified for the purposes of grid box optimization and docking. Nuciferine demonstrated a binding energy of –7.0 kcal/mol and a Ki of 5 µM, both of which were comparatively higher than the corresponding values of kojic acid, which showed –5.3 kcal/mol and 122 µM respectively. Therefore, nuciferine is a potent natural tyrosinase inhibitor and shows promising potential for application in the treatment of hyperpigmentation and skin melanoma.

Keyword

ascorbic acid; hyperpigmentation; kojic acid; melanin; nuciferine; resorcinol; tyrosinase inhibitors